Galmed Pharmaceuticals Announces the Commencement of Patient Screening in the ARREST Study in the United States and Latin America, and Reports Second Quarter 2015 Financial Results
Go back to Galmed Pharmaceuticals Announces the Commencement of Patient Screening in the ARREST Study in the United States and Latin America, and Reports Second Quarter 2015 Financial Results| GALMED PHARMACEUTIC (NASDAQ: GLMD) | Delayed: 0.56 -0.02 (3.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.58 | 52 Week High | $9.70 | |||
| Open | $0.55 | 52 Week Low | $2.78 | |||
| Day High | $0.61 | P/E | N/A | |||
| Day Low | $0.53 | EPS | $0.00 | |||
| Volume | 755,194 | |||||
